- Home
- SWVL vs ECOR Comparison
SWVL vs ECOR Comparison
Compare SWVL & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWVL
- ECOR
- Stock Information
- Founded
- SWVL 2017
- ECOR 2005
- Country
- SWVL United Arab Emirates
- ECOR United States
- Employees
- SWVL N/A
- ECOR N/A
- Industry
- SWVL Business Services
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SWVL Consumer Discretionary
- ECOR Health Care
- Exchange
- SWVL Nasdaq
- ECOR Nasdaq
- Market Cap
- SWVL 44.5M
- ECOR 50.1M
- IPO Year
- SWVL N/A
- ECOR 2018
- Fundamental
- Price
- SWVL $4.37
- ECOR $5.22
- Analyst Decision
- SWVL
- ECOR Strong Buy
- Analyst Count
- SWVL 0
- ECOR 2
- Target Price
- SWVL N/A
- ECOR $25.50
- AVG Volume (30 Days)
- SWVL 6.5K
- ECOR 84.4K
- Earning Date
- SWVL 07-01-2025
- ECOR 08-06-2025
- Dividend Yield
- SWVL N/A
- ECOR N/A
- EPS Growth
- SWVL N/A
- ECOR N/A
- EPS
- SWVL N/A
- ECOR N/A
- Revenue
- SWVL $17,207,362.00
- ECOR $26,458,000.00
- Revenue This Year
- SWVL N/A
- ECOR $23.21
- Revenue Next Year
- SWVL N/A
- ECOR $44.10
- P/E Ratio
- SWVL N/A
- ECOR N/A
- Revenue Growth
- SWVL N/A
- ECOR 41.54
- 52 Week Low
- SWVL $2.40
- ECOR $4.47
- 52 Week High
- SWVL $8.25
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- SWVL 51.73
- ECOR 45.50
- Support Level
- SWVL $3.95
- ECOR $5.05
- Resistance Level
- SWVL $4.45
- ECOR $5.81
- Average True Range (ATR)
- SWVL 0.21
- ECOR 0.32
- MACD
- SWVL -0.08
- ECOR 0.05
- Stochastic Oscillator
- SWVL 44.68
- ECOR 39.84
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.